共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R022969-25mg | 25mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
罗恩 | R022969-50mg | 50mg | 5~7个工作日 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
罗恩 | R022969-100mg | 100mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
罗恩 | R022969-250mg | 250mg | 5~7个工作日 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
罗恩 | R022969-1g | 1g | 5~7个工作日 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
阿拉丁 | M127160-5mg | 5mg | 现货 |
MK-1775,Wee1激酶小分子抑制剂 MK-1775 |
Moligand™, ≥98% |
|
|
阿拉丁 | M127160-10mg | 10mg | 现货 |
MK-1775,Wee1激酶小分子抑制剂 MK-1775 |
Moligand™, ≥98% |
|
|
阿拉丁 | M127160-25mg | 25mg | 现货 |
MK-1775,Wee1激酶小分子抑制剂 MK-1775 |
Moligand™, ≥98% |
|
|
阿拉丁 | M127160-50mg | 50mg | 现货 |
MK-1775,Wee1激酶小分子抑制剂 MK-1775 |
Moligand™, ≥98% |
|
|
阿拉丁 | A408386-1ml | 1ml | 现货 |
Adavosertib (MK-1775) Adavosertib (MK-1775) |
Moligand™, 10mM in DMSO |
|
|
阿拉丁 | M127160-100mg | 100mg | 现货 |
MK-1775,Wee1激酶小分子抑制剂 MK-1775 |
Moligand™, ≥98% |
|
|
阿拉丁 | M127160-500mg | 500mg | 现货 |
MK-1775,Wee1激酶小分子抑制剂 MK-1775 |
Moligand™, ≥98% |
|
|
毕得 | BD238532-10mg | 10mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
毕得 | BD238532-50mg | 50mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
毕得 | BD238532-100mg | 100mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
毕得 | BD238532-25mg | 25mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
毕得 | BD238532-250mg | 250mg | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
毕得 | BD238532-1g | 1g | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
毕得 | BD238532-5g | 5g | 现货 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-Allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
韶远 | SY258875-0.25g | 0.25g | 现货 |
2-烯丙基-1-[6-(2-羟基-2-丙基)-2-吡啶基... 2-Allyl-1-[6-(2-hydroxy-2-pr... |
≥95% |
|
|
韶远 | SY258875-1g | 1g | 现货 |
2-烯丙基-1-[6-(2-羟基-2-丙基)-2-吡啶基... 2-Allyl-1-[6-(2-hydroxy-2-pr... |
≥95% |
|
|
TRC | M424975-5mg | 5mg | 期货,请咨询 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... MK 1775 -20度保存 |
>95% |
|
|
TRC | M424975-10mg | 10mg | 期货,请咨询 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... MK 1775 |
>95% |
|
|
TRC | M424975-50mg | 50mg | 期货,请咨询 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... MK 1775 |
>95% |
|
|
Matrix | MA120722-100mg | 100mg | 3-4周 |
2-Allyl-1-(6-(2-hydroxypropa... 2-Allyl-1-(6-(2-hydroxypropa... |
97% | 咨询 | 请联系客服购买! |
Matrix | MA120722-250mg | 250mg | 3-4周 |
2-Allyl-1-(6-(2-hydroxypropa... 2-Allyl-1-(6-(2-hydroxypropa... |
97% | 咨询 | 请联系客服购买! |
安耐吉 | A053117-100mg | 100mg | 期货,请咨询 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-allyl-1-(6-(2-hydroxypropa... |
97% |
|
|
安耐吉 | A053117-1g | 1g | 期货,请咨询 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-allyl-1-(6-(2-hydroxypropa... |
97% |
|
|
安耐吉 | A053117-250mg | 250mg | 期货,请咨询 |
2-烯丙基-1-(6-(2-羟基丙-2-基)吡啶-2-基... 2-allyl-1-(6-(2-hydroxypropa... |
97% |
|
|
源叶 | S81160-5mg | 5mg | 现货 |
Adavosertib (AZD1775; MK-177... 2-allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
源叶 | S81160-10mg | 10mg | 现货 |
Adavosertib (AZD1775; MK-177... 2-allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
源叶 | S81160-50mg | 50mg | 现货 |
Adavosertib (AZD1775; MK-177... 2-allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
源叶 | S81160-100mg | 100mg | 现货 |
Adavosertib (AZD1775; MK-177... 2-allyl-1-(6-(2-hydroxypropa... |
98% |
|
|
源叶 | T88381-1ml | 1ml | 期货,请咨询 |
Adavosertib (MK-1775) Adavosertib (MK-1775) |
10mM in DMSO |
|
|
Target Mol | T2077-1mg | 1mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-2mg | 2mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-5mg | 5mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-10mg | 10mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-50mg | 50mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-100mg | 100mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-200mg | 200mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-1mL | 1mL | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-25mg | 25mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Target Mol | T2077-500mg | 500mg | 现货 |
化合物 Adavosertib Adavoserti |
99.82% |
|
|
Combi | QJ-1903-250mg | 250mg | 请咨询 |
1-[6-(2-hydroxypropan-2-yl)p... 1-[6-(2-hydroxypropan-2-yl)p... |
95% | 咨询 | 请联系客服购买! |
Combi | QJ-1903-1g | 1g | 请咨询 |
1-[6-(2-hydroxypropan-2-yl)p... 1-[6-(2-hydroxypropan-2-yl)p... |
95% | 咨询 | 请联系客服购买! |
Am | A399066-1mg | 1mg | 现货 |
MK-1775 MK-1775 |
98% |
|
|
Am | A399066-10mg | 10mg | 现货 |
MK-1775 MK-1775 |
98% |
|
|
Am | A399066-50mg | 50mg | 现货 |
MK-1775 MK-1775 |
98% |
|
|
Am | A399066-5mg | 5mg | 现货 |
MK-1775 MK-1775 |
98% |
|
|
Am | A399066-100mg | 100mg | 现货 |
MK-1775 MK-1775 |
98% |
|
|
MCE | HY-10993-200mg | 200mg | 现货 |
Adavosertib Adavoserti |
99.97% |
|
|
MCE | HY-10993-100mg | 100mg | 现货 |
Adavosertib Adavoserti |
99.97% |
|
|
MCE | HY-10993-50mg | 50mg | 现货 |
Adavosertib Adavoserti |
99.97% |
|
|
MCE | HY-10993-10mg | 10mg | 现货 |
Adavosertib Adavoserti |
99.97% |
|
|
MCE | HY-10993-10mM*1mL | 10mM*1mL | 现货 |
Adavosertib Adavoserti |
99.97% |
|
|
MCE | HY-10993-5mg | 5mg | 现货 |
Adavosertib Adavoserti |
99.97% |
|
|